Literature DB >> 31770327

Improvement in Patient Mental Well-being After Surgery for Cervical Spondylotic Myelopathy.

Koji Tamai1, Akinobu Suzuki, Hidetomi Terai, Masatoshi Hoshino, Hiromitsu Toyoda, Shinji Takahashi, Shoichiro Ohyama, Yusuke Hori, Akito Yabu, Hiroaki Nakamura.   

Abstract

STUDY
DESIGN: Retrospective cohort study.
OBJECTIVE: The aim of this study was to investigate changes in mental well-being after surgery for cervical spondylotic myelopathy (CSM) and identify factors associated with improvement. SUMMARY OF BACKGROUND DATA: Posterior cervical surgery with laminoplasty significantly improves myelopathy and physical function in patients with CSM. However, its impact on mental well-being is unclear.
METHODS: Patients who underwent laminoplasty for CSM and had >2 years of follow-up were reviewed (n = 111). The mental component summary (MCS) score was used as a measure of mental well-being. The trend in MCS score change was evaluated using the Jonckheere-Terpstra trend test. Preoperative clinical scores were compared between patients with improvements greater and less than the minimal clinically important difference (MCID). Significant variables were included in a multinomial logistic regression analysis and further validated in a receiver-operating characteristic (ROC) curve analysis. Additionally, the results were confirmed in a long-term observation cohort of patients followed up for >5 years (n = 46).
RESULTS: The improvement in the average MCS score (5.6) was greater than the MCID (4.0). The trend of improvement was sustained for 2 years (P = 0.002), but not for 5 years (P = 0.130). In terms of individual cases, 56 patients (50.5%) achieved MCS score improvement greater than the MCID. These patients showed significantly lower preoperative MCS scores than those without meaningful improvement (P < 0.001). The preoperative "social functioning (SF)" score was independently associated with MCS score improvement (P = 0.001). ROC curve analysis validated the ability of preoperative SF to predict MCS score improvement at 2 and 5 years postoperatively (area under the curve: 0.744, 0.893, respectively).
CONCLUSION: Half of the patients achieved meaningful improvement in mental well-being. A lower preoperative SF score was independently associated with improvement. These results may help identify patients who could experience an improvement in mental well-being after surgery and develop novel approaches to achieve further improvement. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2020        PMID: 31770327     DOI: 10.1097/BRS.0000000000003337

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  4 in total

1.  Improvements in Mental Well-Being and its Predictive Factors in Patients who Underwent Cervical versus Lumbar Decompression Surgery.

Authors:  Koji Tamai; Akinobu Suzuki; Hiromitsu Toyoda; Hidetomi Terai; Masatoshi Hoshino; Shinji Takahashi; Yusuke Hori; Akito Yabu; Hiroaki Nakamura
Journal:  Spine Surg Relat Res       Date:  2021-06-11

2.  Clinical Efficacy and Safety of Anterior Cervical Decompression versus Segmental Fusion and Posterior Expansive Canal Plasty in the Treatment of Multilevel Cervical Spondylotic Myelopathy.

Authors:  Chen Xia; Fangfang Shi; Chuyong Chen; Jun Lv; Qi Chen
Journal:  J Healthc Eng       Date:  2022-04-11       Impact factor: 3.822

3.  Change in Physical and Mental Quality-of-Life between the Short- and Mid-Term Periods after Cervical Laminoplasty for Cervical Spondylotic Myelopathy: A Retrospective Cohort Study with Minimum 5 Years Follow-up.

Authors:  Koji Tamai; Akinobu Suzuki; Hidetomi Terai; Minori Kato; Hiromitsu Toyoda; Shinji Takahashi; Akito Yabu; Yuta Sawada; Masayoshi Iwamae; Hiroaki Nakamura
Journal:  J Clin Med       Date:  2022-09-04       Impact factor: 4.964

4.  Is depression the contraindication of anterior cervical decompression and fusion for cervical spondylosis?

Authors:  Xiaolu Chen; Xiao Li; Yu Gan; Ying Lu; Yu Tian; Yixiao Fu; Hanjie Yang; Ke Liu; Yinlian Pan; Xing Du
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-30       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.